Request Deal Involvement

Novus Therapeutics completed the acquisition of Anelixis Therapeutics.

Identify your role

Select the side you represented in this transaction, and provide your current job title.

Service Providers

Goodwin Procter

legal advisors

Goodwin Procter

Leerink Partners

financial advisors

Leerink Partners

Ladenburg Thalmann

financial advisors

Ladenburg Thalmann

Gibson Dunn & Crutcher

legal advisors

Gibson Dunn & Crutcher

Noble Capital Markets

financial advisors

Noble Capital Markets

Verge Scientific Communications

pr advisors

Verge Scientific Communications

or

Principals

ANELIXIS THERAPEUTICS

target

ANELIXIS THERAPEUTICS

NOVUS THERAPEUTICS

bidder

NOVUS THERAPEUTICS

Principals or Service Provider not listed?Add missing Service Provider or Principal

Enter your Job Title on this deal

This title will appear on your profile next to this deal involvement.


To help us verify your involvement, please include links to any relevant publications that mention you or your company's role in this deal:

All rights reserved. Copyright © 2025 Datasite

MergerLinks - Request Credit - Novus Therapeutics completed the acquisition of Anelixis Therapeutics.